| 000 | 01137 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250517081122.0 | ||
| 264 | 0 | _c20160810 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1474-4465 | ||
| 024 | 7 |
_a10.1016/S1474-4422(16)00042-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPerucca, Emilio | |
| 245 | 0 | 0 |
_aThe safety of generic substitution in epilepsy. _h[electronic resource] |
| 260 |
_bThe Lancet. Neurology _cApr 2016 |
||
| 300 |
_a344-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 |
_aAnticonvulsants _xpharmacology |
| 650 | 0 | 4 |
_aDrug Substitution _xstandards |
| 650 | 0 | 4 |
_aDrugs, Generic _xpharmacology |
| 650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 650 | 0 | 4 |
_aTriazines _xpharmacology |
| 650 | 0 | 4 |
_aUnited States Food and Drug Administration _xstandards |
| 773 | 0 |
_tThe Lancet. Neurology _gvol. 15 _gno. 4 _gp. 344-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1474-4422(16)00042-9 _zAvailable from publisher's website |
| 999 |
_c25731901 _d25731901 |
||